Epidemiology of Clinically Significant Aspergillus Species from a Large Tertiary Hospital in Shanghai, China, for the Period of Two Years
Yuyi Zhang,Suzhen Wang,Chunmei Zhou,Yao Zhang,Jue Pan,Baishen Pan,Beili Wang,Bijie Hu,Wei Guo
DOI: https://doi.org/10.2147/IDR.S417840
2023-07-18
Infection and Drug Resistance
Abstract:Yuyi Zhang, 1 Suzhen Wang, 1 Chunmei Zhou, 1 Yao Zhang, 2 Jue Pan, 2 Baishen Pan, 1 Beili Wang, 1 Bijie Hu, 2 Wei Guo 1 1 Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China; 2 Department of Infectious Disease, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China Correspondence: Wei Guo, Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Shanghai, 200032, People's Republic of China, Tel/Fax +86-21-64041990-2376, Email Bijie Hu, Department of Infectious Disease, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Shanghai, 200032, People's Republic of China, Tel/Fax +86-21-64041990-2328, Email Background: Aspergillus species are becoming a major public health concern worldwide due to the increase in the incidence of aspergillosis and emergence of antifungal resistance. In this study, we surveyed all Aspergillus species isolated from aspergillosis patients in Zhongshan Hospital Fudan University, Shanghai, China, from 2019 to 2021. Methods: We characterized the susceptibility profiles of these Aspergillus species to medical azoles (voriconazole, itraconazole and posaconazole) using YeastOne TM broth microdilution system. To determine the underlying antifungal resistance mechanisms in azole-resistant A. fumigatus (AR Af ) isolates, we characterized mutations in the cyp51A gene. Genotypic diversity of sampled A. fumigatus was investigated using CSP-typing. Results: A total of 112 Aspergillus isolates (81 A. fumigatus , 17 A. flavus , 5 A. niger , 2 A. terreus , 2 A. lentulus , 2 A. oryzae , 1 A. nidulans , 1 A. versicolor and 1 A. sydowii ) from 105 patients diagnosed with aspergillosis (including proven or probable invasive aspergillosis, chronic pulmonary aspergillosis, allergic bronchopulmonary aspergillosis and cutaneous aspergillosis) were obtained. Eight isolates (7 A. fumigatus and 1 A. niger ) from seven patients were either azole non-susceptible or non-wild type. Azole non-susceptible or non-wild type rate was 7.1%/isolate and 6.7%/patient analysed. Four AR Af harbored TR34/L98H mutation, whereas one carried TR46/Y121F/T289A allele. The 81 A. fumigatus isolates were spread across 8 CSP types with t01 to be the predominant type (53.1%). AR Af isolates were distributed over CSP types t01, t02, t04A and t11. Conclusion: Results from this study provided us with an understanding of the antifungal resistance and related characteristics of Aspergillus species in Eastern China. Further comparisons of our results with those in other countries reflect potential clonal expansion of A. fumigatus in our region. Further surveillance study is warranted to guide antifungal therapy and for epidemiological purposes. Keywords: Aspergillus fumigatus , aspergillosis, antifungal susceptibility profile, non-susceptible, non-wild type, CSP-typing Aspergillus species are a group of globally distributed filamentous ascomycete molds which grow ubiquitously in nature. 1 Over 800 Aspergillus species have been recorded and described. 2 Infections with Aspergillus species lead to aspergillosis which contains a broad spectrum of illnesses including allergic bronchopulmonary aspergillosis (ABPA), chronic pulmonary aspergillosis (CPA) to life-threatening invasive aspergillosis (IA). 3 The annual incidence of CPA and IA in the world is estimated to be 3 million cases and over 250,000 cases, respectively. 4 The case-fatality rate associated with aspergillosis has been reported to be 20%–72% depending on the underlying conditions of the patients. 5,6 Aspergillosis has become a public health concern worldwide, while routine antifungal susceptibility testing for Aspergillus species has not been a common practice in clinical microbiology laboratories in many places including China. In addition, the susceptibility data of Aspergillus species to commonly used antifungals as well as the association to clinical outcomes are still lacking, especially for infections with azole-resistant A. fumigatus (AR Af ). In 2022, WHO developed its first fungal priority pathogens list with A. fumigatus ranked the highest for perceived public health importance. 7 Azole agents target and inhibit the biosynthesis of cytochrome P450 sterol 14α-demethylase (CYP51A), which in turn inhibits the cell -Abstract Truncated-
pharmacology & pharmacy,infectious diseases